• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 188
  • 133
  • 38
  • 20
  • 17
  • 13
  • 13
  • 10
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 497
  • 497
  • 497
  • 163
  • 147
  • 65
  • 60
  • 45
  • 37
  • 36
  • 28
  • 26
  • 26
  • 25
  • 25
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
471

Infecções respiratórias por bocavirus humano: aspectos clínicos e moleculares / Respiratory infections by human bocavirus: molecular and clinical features.

José Luiz Proença Modena 20 May 2009 (has links)
O bocavirus humano (HBoV) é um parvovirus recentemente identificado em associação com a presença de sintomas de infecção do trato respiratório. Esse vírus possui um genoma de aproximadamente 5217 nucleotídeos que contém 3 open reading frames que codificam 4 proteínas (NS1, NP-1, VP-1 e VP-2). HBoV tem sido detectado em amostras respiratórias de diversas partes do mundo, incluindo Austrália, América do Norte, Europa, Ásia e África, o que sugere uma distribuição global desse vírus. Entretanto, nenhum estudo longitudinal de HBoV em amostras respiratórias foi realizado na América Latina. Dessa forma, nós realizamos um estudo prospectivo de HBoV em lavados nasofaríngeos (LFNs) coletados de pacientes com sintomas de infecção do trato respiratório (IRA) atendidos em um hospital universitário de Ribeirão Preto, SP e em um hospital universitário de Salvador, BA no período entre 2005 a 2007. 1288 LFNs de 1217 pacientes foram encaminhados ao laboratório de virologia e foram testados por PCR para HBoV. Desses pacientes, 962 eram menores de 5 anos e 177 eram maiores de 5 anos. Além disso, também foram analisados 50 LFNs de crianças menores de 5 anos que não tinham sintomas respiratórios. Todas as amostras positivas para HBoV foram testadas para todos os outros vírus respiratórios, incluindo o vírus sincicial respiratório (HRSV), rinovirus humano (HRV), influenza humano (HFLU), metapneumovirus humano (HMPV), parainfluenza humano (HPIV), coronavirus humano (HCoV) e adenovirus humano (HAdV). A carga viral de HBoV foi determinada por PCR em tempo real em todas as amostras positivas e o genoma completo de 19 amostras de HBoV foi seqüenciado. Com intuito, de fazer um levantamento sorológico e determinar sítios replicativos de HBoV, nós ainda clonamos e expressamos em S. cerevisae (Y258) o gene de VP2, que codifica uma das proteínas do capsídeo viral. A prevalência desse vírus foi de 4,8% em crianças menores de cinco anos e de 1% em pacientes maiores de cinco anos. HBoV não foi detectado em crianças sem sintomas. Dos 259 pacientes analisados em 2005, 25 (10%) foram positivos para HBoV. Esse vírus circulou mais frequentemente em abril, mês de maior incidência do HRSV. Em 2006, HBoV foi detectado em apenas 10 LFNs de 334 (3%) amostras testadas, sem qualquer pico de freqüência. Em 2007 HBoV foi detectado em 13 de 552 (2%) amostras, com uma freqüência de detecção um pouco maior em junho e julho. Os sintomas mais comumente observados foram rinorréia, tosse, febre e chiado, que foram observados geralmente em mais de 50% dos casos positivos para HBoV. Não houve uma diferença significativa na prevalência desses sintomas entre as crianças positivas e negativas para HBoV. Entretanto, foi observada uma maior freqüência de diarréia entre as crianças com esse vírus. Nesse estudo também foi documentado uma alta freqüência de co-infecções virais entre os pacientes com HBoV. Os vírus mais frequentemente associados com o bocavirus humano foram: HRSV, HRV e HAdV. Além disso, foi detectado uma maior carga viral media e uma maior freqüência de diarréia nos 15 pacientes com infecção exclusiva por HBoV do que nos pacientes com co-infecção. Esses resultados mostraram que HBoV pode alcançar títulos enormes (tão grandes como1014/mL) em LFNs de pacientes com sintomas respiratórios e que isso é associado a de diarréia. O seqüenciamento do genoma inteiro de HBoV realizado nesse estudo indica que a divergência genômica entre as amostras desse vírus é muito pequena. Como conclusão, nós demonstramos que HBoV circula e é detectado em associação com sintomas de infecção respiratória e diarréia no Brasil. Novos estudos, com um longo acompanhamento em diferentes populações serão necessários para determinar a sazonalidade e o real impacto clínico de HBoV em nosso país. / Human bocavirus (HBoV) is a parvovirus recently identified in association with respiratory tract infections. HBoV 5217 nt genome contains 3 open reading frames encoding four proteins (NS1, NP-1, VP-1 and VP-2). HBoV has been reported in respiratory samples from children in several parts of the world (including Australia, North America, Europe, Asia, and Africa), suggesting that the virus circulates worldwide. However, no longitudinal studies of HBoV in respiratory samples have been reported in Latin America. We report a prospective study of HBoV in nasopharyngeal aspirates (NPAs) collected from patients seen for acute respiratory tract infections (ARI) at the University of Sao Paulo Hospital in Ribeirao Preto, southeast Brazil and at the University Hospital in Salvador, Brazil. 1288 NPAs from 1217 patients was submitted to the virology lab for respiratory virus detection from 2005 to 2007 and were screened for HBoV by polymerase chain reaction (PCR), whom 962 were under 5 years of age and 177 were older than 5 years. In addition, NPAs from 50 children under 12 years without IRA was also tested to HBoV for PCR. All samples positive of HBoV was tested for others respiratory virus, including the human respiratory syncitial virus (HRSV), human rhinovirus (HRV), human influenza (HFLU), human metapneumovirus (HMPV), human parainfluenza virus (HPIV), human coronavirus (HCoV) and human adenovirus (HAdV). These samples had their HBoV viral load determined by real time PCR and the viral entire genome of nineteen HBoV sample was sequenced. We also cloned and expressed in S. cerevisae (Y258) the gene of VP2, one protein of viral capside. The prevalence of this virus was of 4,8% in children under 5 years and 1% in adults, both with IRA. HBoV was not found on the patients without symptoms. In 2005, of the 259 patients tested, 25 (10%) were positive for HBoV. Interestingly, the virus circulated more frequently in April, the month of peak activity of respiratory HRSV. In 2006 HBoV was detected in only 10 NPAs out of 334 samples (3%) tested, without any notable peak of frequency. In 2007 HBoV was detected in 13 out of 552 (2%) tested samples with little higher frequency of detection in June an July. Rhinorrhea, cough, and wheezing were observed in more than 50% of the HBoV-positive children, and no obvious respiratory clinical differences were noted between HBoV-positive and negative children. However, was noted a higher frequency of diarrhea on HBoV-positive patients. In this study was also observed a larger frequency (71%) of viral coinfections between the HBoV-positive patients. The respiratory viruses more frequently associated with human bocavirus were: HRSV, HRV and HAdV. Interestingly, on the 15 HBoV-alone patients was observed a higher viral load and a higher prevalence of diarrhea than HBoV-coinfection patients. These results showed that this virus can reach enormous titles (like 1014) in NPAs from patients with respiratory infection symptoms and this is associated with diahhrea. The entire genome sequencing of HBoV of our study indicates that the genetic divergence between the HBoV lineages is small. In conclusion, we demonstrated that HBoV circulates and is detected in association with respiratory symptoms and diarrhea in Brazil. Long term surveillance will be needed to determine whether or not an HBoV season occurs and what is the real clinical impact of this virus in our country.
472

Caracterização do diagnóstico clínico e detecção no gene da distrofia muscular de Duchenne/Becker no Rio Grande do Sul por PCR quantitativo em tempo real

Franco, Carolina Rosa January 2007 (has links)
A Distrofia Muscular de Duchenne/Becker (DMD/BMD) é a doença neuromuscular mais freqüente em crianças, afetando uma em cada 3.500 nascidos vivos do sexo masculino (DMD), e um em cada 20.000 (BMD). A criança nasce aparentemente saudável, com o aparecimento gradual e progressivo dos sintomas desde o primeiro ano de vida. A perda da habilidade de caminhar se dá entre os sete e 12 anos de idade, com sobrevivência rara acima dos 30 anos; e a BMD, de forma mais amena, com os mesmos sintomas aparecendo mais tardiamente. O diagnóstico se baseia nas características clínicas e na investigação genética de deleções e duplicações no gene da distrofina. Um teste preciso ainda é necessário para a identificação de mulheres portadoras. O PCR quantitativo em tempo real seria um bom ensaio para a determinação deste status.O objetivo deste trabalho foi identificar as mulheres portadoras de deleções no gene da distrofina através de PCR quantitativo em tempo real e apresentar informações diagnósticas sobre a população de meninos com DMD/BMD do RS. Informações pertinentes a 123 meninos com diagnostico clínico foram incluídos neste estudo. Após análise dos exames de DNA nos meninos estudados, os exons 47, 48 e 50 se mostraram mais frequentemente deletados na nossa população, confirmando que o segundo "hotspot" gênico é o que mais sofre alterações. Cinco mulheres com filhos com deleções nos exons 45, 47 e 51 foram testadas para estabelecimento do seu status de portadora ou não-portadora. A comparação direta dos exons específicos em relação aos mesmos em outras mulheres, determinou, com uma fácil visualização, a confirmação de três mulheres portadoras e duas não-portadoras, sendo um método preciso e efetivo. É uma abordagem prática e importante para uma utilização em casos de duplicações neste mesmo gene e em outros que necessitem deste tipo de quantificação exata. / Duchenne/Becker Muscular dystrophy (DMD/BMD) is the most frequent neuromuscular disorder in children, affecting one in every 3,500 born male boys (DMD), and one in every 20,000 (BMD). The child is born apparently healthy, with a gradual and progressive appearance of the symptoms during the first year of life. Between the ages of seven to 12, the child demonstrates a loss of the ability to walk, with rare survival above 30 years; and BMD, a milder form, with similar symptoms delayed. The diagnosis is based on the clinical characteristics and a genetic investigation of deletions and duplications in the dystrophin gene. A precise test is still necessary for the identification of carrier women. A quantitative real-time PCR would be a good assay for the determination of this status. The main goals of this study were to identify the carrier women of deletions in the dystrophin gene through the quantitative real-time PCR and to present the diagnostic information available for the population of boys with DMD/BMD in RS. Information pertaining to 123 boys with a clinical diagnosis was included in this study. After the analysis of the boy´s DNA exams, exons 47, 48, and 50 were the most frequently deleted in our population, confirming that the second genetic hospot suffers most of the alterations. Five women that bore children with deletions in exons 45, 47, and 51 were tested for the establishment of their carrier or non-carrier status. A direct comparison of the specific exons to the same ones in other women determined, with an easy visualization, the confirmation of three carrier women and two non-carrier, being a precise and effective method. It is a practical and important approach for the use in cases of duplication in this same gene and in others that may need an exact quantification.
473

"Efeito modulatório da nicotina sobre a neurotransmissão em núcleos encefálicos responsáveis pelo controle cardiovascular em ratos geneticamente hipertensos e normotensos" / "Nicotine modulatory effects on neurotransmiter systems in the cardiovascular brain areas of spontaneously hypertensive and normotensive rats"

Merari de Fatima Ramires Ferrari 25 May 2006 (has links)
As ações cardiovasculares decorrentes do tabagismo devem-se principalmente à nicotina. O alcalóide exerce suas funções quando na corrente sangüínea, mas também atravessa a barreira hemato-encefálica onde pode participar da regulação de sistemas de neurotransmissão importantes para o controle central da pressão arterial e, eventualmente, desenvolvimento da hipertensão. Portanto, o abuso à nicotina pode ser especialmente relevante para indivíduos com predisposição genética à hipertensão. Desta forma, os objetivos do presente trabalho foram o de estudar os sistemas de neurotransmissão em núcleos encefálicos envolvidos no controle cardiovascular após tratamento crônico periférico com nicotina, assim como avaliar a influência da nicotina sobre o desenvolvimento da hipertensão essencial em ratos espontaneamente hipertensos (SHR) e compará-los a ratos normotensos (WKY). Para isso, utilizaram-se técnicas como a imunohistoquímica, análise da ligação de receptores, hibridização in situ, cultura de células neuronais e gliais, PCR em tempo Real e Western Blotting. Nossos resultados demonstraram que o tratamento crônico com nicotina não só antecipou o desenvolvimento como também intensificou a hipertensão nos animais SHR. Os ratos WKY não tiveram a pressão arterial alterada. De modo geral, o efeito do alcalóide sobre os sistemas catecolaminérgico e do neuropeptídeo Y não parece ter relação com a antecipação e a intensificação da hipertensão nos ratos SHR. O sistema glutamatérgico está, pelo menos em parte, relacionado à antecipação e intensificação da hipertensão em ratos SHR após exposição crônica à nicotina. O tratamento com nicotina gerou evidências de que o alcalóide interage com o sistema angiotensinérgico a fim de promover a hipertensão em ratos SHR. Por fim, os resultados apresentados aqui indicam que a nicotina modula diferentes sistemas de neurotransmissão, os quais podem estar envolvidos na antecipação e intensificação da hipertensão em ratos SHR submetidos ao tratamento com nicotina. / Nicotine is one of the most important agents for cardiovascular diseases in tobacco smoking. This alkaloid acts in the blood stream, but it also crosses the blood-brain-barrier and participate in the regulation of pivotal neurotransmitter systems for the blood pressure control and, eventually, for hypertension development. In this context, nicotine abuse could be very relevant to individuals carrying genetic factors to hypertension. The objectives of the present work were to study neurotransmitter system in brain cardiovascular areas involved in the control of blood pressure after chronic peripheral nicotine exposure, as well as to evaluate nicotine influence on essential hypertension development in spontaneously hypertensive (SHR) and normotensive rats (WKY). By means of immunohistochemistry, binding, in situ hybridization, neuron and glial culture, real time PCR and Western Blotting, we have demonstrated that chronic treatment with nicotine not only anticipated but also intensified hypertension on SHR. WKY rats did not showed any change on blood pressure. We observed no evidences of the involvement of neuropeptide Y and catecolamines systems in the development of hypertension after nicotine treatment. However, it seems that the glutamatergic system is, at least in part, responsible for the hypertension development after chronic nicotine exposure. To study the angiotensinergic system we cultivated neuron and glial cells from SHR and WKY rats and treated them with nicotine. The responses of this system agree with the hypothesis that nicotine interacts with angiotensin to promote hypertension only in the hypertensive strain. In conclusion, results presented herein support the hypothesis that nicotine modulates neurotransmitter systems that might have relevant functions in the development and intensification of hypertension in SHR.
474

Possível envolvimento da Chlamydia pneumoniae e Mycoplasma pneumoniae na resposta inflamatória da aterosclerose / Possible involvement of Chlamydia pneumoniae and Mycoplasma pneumoniae in the inflammatory response of atherosclerosis

Renata Melo de Assis 20 June 2008 (has links)
A aterosclerose é um processo complexo, multifatorial que ainda não está totalmente esclarecido. Foi proposto que a resposta imune mediada por processos infecciosos e/ou inflamatórios influencia na patogênese de lesões ateroscleróticas. Os receptores TolI-likes (TLRs) estão envolvidos na resposta inata e em outros eventos fisiológicos através da interação com seus ligantes endógenos e exógenos e talvez envolvidos no processo aterogênico. Tem por objetivo analisar a expressão dos receptores Toll-like 2 e 4 (TLR2 e TLR4) associando o processo de sinalização com a presença de agentes infecciosos tais como a Chlamydia pneumoniae (CP) e Mycoplasma pneumoniae (MP), em pacientes com infarto do miocárdio (MI) e em aneurismas aórticos. Foram obtidos fragmentos de aortas ascendentes de pacientes submetidos à cirurgia de revascularização do miocárdio (G1, n=13) e de fragmentos de pacientes submetidos à cirurgia de correção de aneurisma aórtico (G2, n=14). Amostras congeladas e parafinadas foram analisadas por Imunohistoquímica (lHO) e Hibridização in situ (HIS) para detecção e localização da presença dos patógenos e TLRs. Realizou-se uma semiquantificação em microscópio (O, ausente; 1, discreto e focal; 2, moderado e focal e 3, intenso e difuso). Observou-se o grau de inflamação e de acúmulo de gordura. Outrossim, realizou-se PCR em tempo real (SYBR Green) para pesquisa de DNA de CP e MP, como também análise da expressão de mRNA de TLR2 e de TLR4. Na lHQ, constatou-se presença de MP, CP, TLR2 e TLR4 (G1 e G2), maior quantidade de MP (p=0,012) e de TLR4 (p=0,017) no G2. Houve correlação de CP com MP (r=0,810 e p=0,003) e de TLR2 com TLR4 (r=0,569 e p=0,034). Na HIS, constatou-se presença de MP, CP, TLR2 e TLR4 (G1 e G2), não houve diferenças significativas comparando-se os grupos (G1 x G2), porém houve correlação, no G1, de CP com TLR4 (r=0,730 e p=0,040) e de infiltrado inflamatório com células adiposas (r=0,700 e p=0,036). No G2, houve várias correlações: MP com CP (r=0,620 e p=0,016), MP com TLR4 (r=0,662 e p=0,010), CP com TLR2 (r=O,733 e p=0,003), CP com TLR4 (r=0,589 e p=0,027) e de TLR2 com TLR4 (r=0,714 e p=0,004). A PCR em tempo real mostrou presença de CP, pela segunda extração de DNA realizada (G2). Não houve diferença de expressão dos TLRs entre os grupos. A expressão de TLR2 foi maior do que de TLR4 no G1 (p=0,006). O grau de inflamação e o acúmulo de gordura foram maiores no G2 do que no G1(p=0,001). Estes dados sugerem uma relação da co-infecção CP e MP, na gravidade do processo inflamatório presente em placas ateroscleróticas e em pacientes com infarto do miocádio, como também, participação dos receptores Toll-like 2 e 4. / The atherosclerosis is a complex and multifactorial process that is not still completely elucidated. It has been proposed that immune-mediate response to inflammatory and/or infectious processes is implicated in the pathogenesis of the atherosclerotic lesions. Toll-like receptors (TLRs) are involved in the innate response and other physiological events through binding to endogenous and exogenous ligands and it may be involved in the atherogenic process To investigate the Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4) expression in atheroma plaques and its association with the presence of infectious agents such as Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) in patients with myocardial infarction (MI) and aortic aneurysms. Fragments of ascending aorta were obtained from MI patients submitted to surgeries of revascularization of the myocardium (G1, n=13) and correction of aortic aneurism (G2, n=14). Frozen and paraffined samples slices were analyzed by Immunohistochemistry (lHQ) and in situ Hybridization for detection and localization of TLR2 and TLR4 expression and CP and MP antigens. There was semiquantification in microscope (0, absent; 1, discreet and focal; 2, moderate and focal; and 3, intense and diffuse). Histopathology was also carried out to investigate the inflammation degree and fat accumulation in these tissues. Real time PCR using SYBR Green System detection was used to stydy DNA CP and MP, also to analyze expression of mRNA TLR2 and TLR4. Using lHQ, it was verified presence of MP, CP, TLR2 and TLR4 (G1 and G2), larger amount of MP (p=0.012) and TLR4 (p=0.017) in G2. In G1 group, MP was positively correlated with CP (r=0.810, p=0.003), in G2, TLR2 with TLR4 (r=0.569, p=0.034). Using HIS, it was verified presence of MP, CP, TLR2 and TLR4 (G1 and G2), there were not significant differences between groups (G1 x G2), however, It was shown correlation between in G1, CP with TLR4 (r=0.730, p=0.040) and also inflammation with fat accumulation (r=0.700, p=0.036). In G2, there were several correlations: presence of MP with CP (r=0.620, p=0.016), MP with TLR4 (r=0.662, p=0.010), CP with TLR2 (r=0.733 p=0,003), CP with TLR4 (r=0.589, p=0.027) and TLR2 with TLR4 (r=0.714, p=0.004). Real time PCR showed presence of CP DNA using second purification accomplished (G2). There was not difference of expression TLRs among the groups. The expression of TLR2 was higher than TLR4 in G1 (p=0.006). Increased degree of inflammation and fat accumulation was also find in G2 than in G1 (p=0.001). These results are suggesting that the gravity of the inflammatory process in atherosclerotic plaques strongly are related to the presence of MP and CP co infection and expression of TLR2 and TLR4, as well in MI patients under myocardial revascularization.
475

Análise do transcriptoma de Lippia alba (Mill.) N.E.Br. (Verbenaceae) por RNAseq visando a identificação de enzimas terpeno sintases

Souza, Vinicius Carius de 03 March 2016 (has links)
Submitted by isabela.moljf@hotmail.com (isabela.moljf@hotmail.com) on 2017-06-21T14:43:48Z No. of bitstreams: 1 viniciuscariusdesouza.pdf: 3785363 bytes, checksum: 7063d6c5f5cef353643903ad5f125c48 (MD5) / Approved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2017-08-07T19:09:52Z (GMT) No. of bitstreams: 1 viniciuscariusdesouza.pdf: 3785363 bytes, checksum: 7063d6c5f5cef353643903ad5f125c48 (MD5) / Made available in DSpace on 2017-08-07T19:09:52Z (GMT). No. of bitstreams: 1 viniciuscariusdesouza.pdf: 3785363 bytes, checksum: 7063d6c5f5cef353643903ad5f125c48 (MD5) Previous issue date: 2016-03-03 / CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico / FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais / Lippia alba, popularmente conhecida por erva-cidreira, é uma espécie vegetal amplamente distribuída pelas Américas e encontrada praticamente em todo o território brasileiro. Esta espécie possui importante uso na medicina tradicional para o tratamento de cólicas, indigestão, náuseas, espasmos, diarreia, disenteria, doenças respiratórias, problemas hepáticos e no tratamento de sífilis e gonorreia. As folhas de L. alba, as quais são preparadas sob a forma de infusão ou decocção e ingeridas por via oral, produzem um óleo essencial rico em moléculas iso-prenóides denominadas terpenóides. Estes compostos não são apenas de interesse farmacológico, mas também industrial já que são usados na confecção de fragrâncias. A composição dos óleos essenciais pode variar em função de diferentes fatores abióticos e genotípicos, como por exemplo nível de ploidia. Neste contexto, os objetivos deste trabalho foram caracterizar o transcriptoma de folha da espécie L. alba e buscar sequencias putativas de enzimas envolvidas na produção de metabólitos secundários. O transcriptoma foi sequenciado pela plataforma Miseq (Illumina) com bibliotecas pairedend de 300 bp. O sequenciamento resultou em um total de 47.498.310 reads paired-end (23.749.155 reads para cada end sequenciado) de 35-308 bp, compreendendo 12.148.327.567 nucleotídeos (-12 Gb). A montagem de novo dos transcritos foi processada a partir do software Trinity que gerou 193.532 transcritos, sendo 128.209 unigenes, com o valor de N50 igual a 1.187 bp. Um total de 86.122 ORF (Open Read Frame) foi obtido e a seguir submetido ao algoritmo de alinhamentos BlastP, o qual encontrou 75.533 sequências com referência no banco de dados NR (Non-Redundant) de proteínas. Aproxima-damente, 78,4% dessas sequências foram anotadas funcionalmente a partir do pipeline utiliza-do pelo software Blast2GO. As análises das sequências anotadas revelaram prováveis enzimas para síntese de terpenóides como geraniol e linalol/nerolidol. Para validação da montagem e anotação, foram realizados ensaios de qPCR para amplificação de sequências de 13 genes para controles endógenos e 4 genes de terpeno sintases. Os resultados obtidos aqui corroboram outros estudos de transcriptoma de espécies não modelo usando tecnologias de sequenciamento de alto-desempenho. / Lippia alba, popularly known as erva-cidreira, is a widely distributed specie in Americas and it is found throughout Brazil. This specie has important using in popular medicine for cramp-ing, indigestion, nausea, diarrhea, dysentery, respiratory diseases, liver disorders treatment and infectious diseases such as syphilis and gonorrhea. The leaves of L. alba, which are pre-pared by infusion or decoction and orally ingested, producing an essential oil rich in terpene compounds. These compounds are of pharmacological and industrial interest, due to their use in fragrance preparation. Interestingly, the composition of essential oils change according to different abiotic factors and genetic variations such as ploidy level. In this context, the aims of this work were to characterize the transcriptome of leaves of L. alba (linalool chemotype) and to search putative enzymes sequences involved in production of secondary metabolites. The transcriptome was sequenced by Miseq platform (Illumina) running pair-end libraries 300 bp. The sequencing resulted in 47,498,310 reads (23,749,155 reads for each end sequenced) of 35-308 bp, comprising 12,148,327,567 nucleotides (-12 Gb). The de novo assembly of tran-scripts was processed by Trinity software and generated 193,532 transcripts, in 128,209 uni-genes, with N50 equal to 1,187 bp. 86,122 ORFs (Open Read Frame) were obtained and sub-mitted to BlastP algorithm, finding 75,533 sequences included in NR (Non-Redundant) pro-tein database. Approximately 78.4% of these sequences were functionally annotated using Blast2Go pipeline. Analysis of annotated sequences revealed putative enzymes for synthesis of terpenoids such as geraniol and linalool/nerolidol. For assembly and annotation validation, qPCR assay were realized by amplification of 13 endogenous control genes and 4 terpene synthases genes. The results found here corroborate transcriptome studies in non-model or-ganisms using high-performance sequencing technologies.
476

Développement de méthodes permettant la détection et la quantification de microorganismes d'altération du vin : étude de facteurs de développement / Development of methods for the detection and quantification of spoilage microorganisms in wine : study of growing factors

Longin, Cédric 18 November 2016 (has links)
Les nouvelles pratiques utilisées pour l’élaboration du vin amènent à une recrudescence des altérations microbiennes. C’est pourquoi, de nouvelles méthodes doivent être développées afin de quantifier ces microorganismes de façon précise, rapide et avec de faibles coûts. Les principales altérations du vin sont dues aux bactéries acétiques (BA) (A. aceti, A. pasteurianus, G. oxydans et Ga. liquefaciens) et à Brettanomyces bruxellensis. Par l’action d’enzymes, les 1ères transforment l’éthanol en acide acétique alors que B. bruxellensis transforme les acides hydroxycinnamiques en éthyles phénols (EP) (molécules odorantes désagréables). La cytométrie en flux couplée à la technique d’hybridation in situ en fluorescence a tout d’abord été étudiée. Aucun résultat reproductible n’a été développé pour les BA en vin rouge alors que pour B. bruxellensis, le protocole existant a été amélioré avec une quantification possible en 18 h. La PCR en temps réel a également été utilisées afin de quantifier ces microorganismes. Un protocole a été développé pour la quantification des BA en vin rouge (103 cellules/mL) avec l’utilisation d’un témoin interne microbiologique permettant de valider le rendement de l’extraction de l’ADN. Pour B. bruxellensis, trois kits commerciaux ont été analysés lors d’une étude interlaboratoires. Les quantifications se sont révélées significativement différentes des énumérations sur boite de Pétri avec une quantification des cellules mortes. De plus, il a été étudié et validé l’effet population de B. bruxellensis sur l’efficacité du SO2. Il ressort également de ces expérimentations que les cellules en état viable mais non cultivable ne produisent pas d’EP. / New practices used to elaborate wine lead to an increase of wine spoilage due to microorganisms. That is why, new technics have to be developed to quantify these microorganisms accurately, quickly and with low costs. The main wine spoilages are due to acetic acid bacteria (AAB) (A. aceti, A. pasteurianus, G. oxydans and Ga. liquefaciens) and Brettanomyces bruxellensis development. AAB transforms ethanol to acetic acid while B. bruxellensis transforms hydroxycinnamic acids to ethyl phenols (EP) (unpleasant odor molecules). In order to detect these wine spoilage microrganisms, flow cytometry coupled to fluorescent in situ hybridization has been assessed. No reproducible results have been developed for AAB in red wine while for B. bruxellensis, the existing protocol has been improved with a possible quantification after 18 h compared to 48-72 h in the previous protocol. The real-time PCR was also used to quantify these microorganisms. A protocol has been developed for the AAB quantification in red wine (103 cells/mL) with the use of a microbiological internal control to validate the DNA yield after extraction. For B. bruxellensis, three commercial kits were analyzed in an interlaboratory study. Quantifications were significantly different to the enumerations by Petri dish, with dead cell quantifications. Moreover, we demonstrated that the effectiveness of sulfite is dependent of the B. bruxellensis population. It also appears from these experiments that cells in viable but not culturable state do not produce EP.
477

Expresní profil kardiovaskulárních microRNA u těhotenství s klinickou manifestací gestační hypertenze, preeklampsie a fetální růstové retardace / The expression profile of cardiovascular disease associated microRNAs in pregnancies with clinical manifestation of gestational hypertension, preeclampsia and intrauterine growth restriction

Bohatá, Jana January 2017 (has links)
MicroRNA (miRNA) are small non-coding 21-23 nucleotides long one strand RNAs. They are among the major posttranscriptional regulators of gene expression that regulate both physiological and pathological processes. Some of microRNAs, amount of their expression respectively, are specific only for certain type of tissue or pathological condition. The hypothesis for my diploma thesis was that gene expression of 28 cardiovascular disease associated microRNAs (miR-1-3p, miR-16-5p, miR-17-5p, miR- 20a-5p, miR-20b-5p, miR-21-5p, miR-23a-3p, miR-24-3p, miR-26a-5p, miR-29a-3p, miR-92a-3p, miR-100-5p, miR-103a-3p, miR-125b-5p, miR-126-3p, miR-130b-3p, miR-133a-3p, miR-143-3p, miR-145-5p, miR-146a-5p, miR-181-5p, miR-195-5p, miR- 199a-5p, miR-210-3p, miR-221-3p, miR-342-3p, miR-499a-5p, miR-574-3p) would differ in umbilical cord blood between groups of women with physiological pregnancies (FG), gestational hypertension (GH), preeclampsia (PE) and fetal growth restriciton (FGR). The studied cohort consisted of 184 pregnant women involving 44 controls, 47 GH pregnancies, 56 PE pregnancies and 37 FGR pregnancies. Relative quantification of microRNAs was performed by quantitative real-time PCR. Results showed a trend to miR-195-5p down-regulation in umbilical cord blood of GH patients. On the other hand, mild PE...
478

Ljungan Virus Replication in Cell Culture

Ekström, Jens-Ola January 2007 (has links)
Ljungan virus (LV) is a recently identified picornavirus of the genus Parechovirus. LV has been isolated from voles trapped in Sweden and also in the United States. LV infected small rodents may suffer from diabetes type 1 and type 2 like symptoms, myocarditis and encephalitis. LV has been proposed as a human pathogen, with indications of causing diabetes type 1, myocarditis and intrauterine fetal deaths. In this thesis, cell culture adapted LV strains were utilised for development and adaptation of several basic methodological protocols to study the LV biology, e.g. real time PCR, highly specific antibodies and a reverse genetics system. These methods allowed detailed studies of this virus and how it interacts with the host cell. The genomic 5'-end was identified and modelling showed unique secondary structure folding of this region. The LV encodes an aphthovirus-like 2A protein with a DvExNPGP motif. This motif was found to mediate primary cleavage of the LV polyprotein in vitro and is proposed to constitute the carboxy terminus of the structural protein VP1 in LV. Rabbit polyclonal antibodies generated against recombinant structural proteins were used to verify that the LV virion is composed of the structural proteins VP0, VP1 and VP3. Cell culture studies showed that LV replicates to low titer with an absent or delayed cell lysis. LV is proposed to be able to spread by a, for picornaviruses, not previously demonstrated direct cell-to-cell transmission. All results taken together suggest a maintenance strategy of LV including low amounts of the LV genome and persistently infected hosts. Stability studies showed that the LV virion not only maintain activity in acidic and alkaline environments but also exhibit resistance to the commonly used disinfectant Virkon®.The results presented in this thesis show that LV has several unique properties, not previously observed for a picornavirus.
479

The Effect of Sample and Sample Matrix on DNA Processing: Mechanisms for the Detection and Management of Inhibition in Forensic Samples

Moreno, Lilliana I 23 March 2015 (has links)
The presence of inhibitory substances in biological forensic samples has, and continues to affect the quality of the data generated following DNA typing processes. Although the chemistries used during the procedures have been enhanced to mitigate the effects of these deleterious compounds, some challenges remain. Inhibitors can be components of the samples, the substrate where samples were deposited or chemical(s) associated to the DNA purification step. Therefore, a thorough understanding of the extraction processes and their ability to handle the various types of inhibitory substances can help define the best analytical processing for any given sample. A series of experiments were conducted to establish the inhibition tolerance of quantification and amplification kits using common inhibitory substances in order to determine if current laboratory practices are optimal for identifying potential problems associated with inhibition. DART mass spectrometry was used to determine the amount of inhibitor carryover after sample purification, its correlation to the initial inhibitor input in the sample and the overall effect in the results. Finally, a novel alternative at gathering investigative leads from samples that would otherwise be ineffective for DNA typing due to the large amounts of inhibitory substances and/or environmental degradation was tested. This included generating data associated with microbial peak signatures to identify locations of clandestine human graves. Results demonstrate that the current methods for assessing inhibition are not necessarily accurate, as samples that appear inhibited in the quantification process can yield full DNA profiles, while those that do not indicate inhibition may suffer from lowered amplification efficiency or PCR artifacts. The extraction methods tested were able to remove >90% of the inhibitors from all samples with the exception of phenol, which was present in variable amounts whenever the organic extraction approach was utilized. Although the results attained suggested that most inhibitors produce minimal effect on downstream applications, analysts should practice caution when selecting the best extraction method for particular samples, as casework DNA samples are often present in small quantities and can contain an overwhelming amount of inhibitory substances.
480

Impact des mycotoxines sur le microbiote intestinal humain, cas particulier du déoxynivalénol / Impact of mycotoxins on the human gut microbiota, particular case of deoxynivalenol

Saint-Cyr, Manuel 18 December 2013 (has links)
Le déoxynivalénol (DON) est une mycotoxine qui contamine la plupart des cultures de céréales dans toutes les régions du monde. Capable de résister aux procédés de transformation subies par les céréales, le DON peut se retrouver alors, à l'état de contaminants dans les matières premières (céréales) ainsi que dans les denrées alimentaires transformées destinées à l'Homme (pâtes, pain, bières) et à l'animal (granulés) à des concentrations supérieures aux limites règlementaires. Malgré les efforts de recherche pour caractériser les multiples aspects de l’impact d’une contamination par le DON, les effets bactériologiques de cette mycotoxine n’étaient pas encore documentés chez l’Homme. L'Agence Nationale de Sécurité Sanitaire (Anses), dans le cadre de sa mission de protection du consommateur, a donc souhaité évaluer l'impact d'une contamination au DON sur le microbiote intestinal humain (MIH). Dans cette étude, nous avons d’abord évalué la cinétique du DON chez le porc et chez le rat, puis nous avons utilisé un modèle de rats à flore humanisée pour évaluer l'impact d'une exposition sub-chronique de la mycotoxine sur la composition du MIH. Le DON est un contaminant rapidement distribué et éliminé. Au sein du tractus digestif, il entraine des changements bactériologiques significatifs chez certains principaux groupes bactériens composant le MIH. Cette étude apporte des données complémentaires à l’analyse du risque lié à l’exposition du DON chez l’Homme et montre l’intérêt des modèles animaux étudiés dans des scénarii particuliers d’exposition au DON. / Deoxynivalenol (DON) is one of the most prevalent mycotoxins present in cereal crops worldwide. Able to withstand the transformation process undergone by grains, DON can be found as contaminant in raw materials (cereals) and in processed food for humans (pasta, bread, beer) and animals (grains) at concentrations upper the control limits. Despite research efforts to characterize various aspects of the impact of DON contamination, the microbiological effects of DON were not documented in humans. The French agency for food, environmental and occupational health and safety (Anses), as part of its mission to protect the consumer, wanted to assess the impact of DON contamination on the Human Gut Microbiota (HGM). In this study, we first evaluated the kinetics of DON in pigs and rats, and then we assessed the impact of an oral subchronic exposure of deoxynivalenol on the composition of HGM in a human microbiota-associated rats model. DON is a contaminant rapidly distributed and eliminated. In gut, DON leads to significant changes in some of the main bacterial groups of the HGM. This study provides additional data to analyze the risk exposure of DON in humans and shows the interest of these animal models in studies dealing with particular scenarios of DON exposure.

Page generated in 0.0642 seconds